☆ 4.6 Article

LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction of EMT

FRONTIERS IN ONCOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Oncology

LncRNA SNHG6 Induces Epithelial-Mesenchymal Transition of Pituitary Adenoma Via Suppressing MiR-944

Dandan Mao et al.

Summary: This study reveals the significant role of SNHG6 and miR-994 in invasive pituitary adenoma (IPA), regulating cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT). SNHG6 can downregulate the expression of miR-944, while miR-944 can repress the expression of RAB11A to affect the above-mentioned processes.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2022)

Add to Collection

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Exosome-Mediated Response to Cancer Therapy: Modulation of Epigenetic Machinery

Mohammad Imran Khan et al.

Summary: Exosomes play a key role in mediating epigenetic modifications in cancer cells, particularly through the delivery of non-coding RNAs such as microRNAs. This modulation of epigenetic events can significantly impact the sensitivity of cancer cells to various therapies. Understanding the mechanisms by which exosomes modulate therapy response is critical for developing novel strategies to overcome cancer drug resistance.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

miR-485-3p and miR-4728-5p as Tumor Suppressors in Pathogenesis of Colorectal Cancer

T. Gurer et al.

Summary: miR-485-3p and miR-4728-5p expression levels were significantly downregulated in CRC tissues, with lower expression of miR-485-3p in both rectum and colon and decreased miR-4728-5p expression associated with age. Bioinformatics analysis identified TFs associated with these miRNAs, suggesting a potential role in early diagnosis and treatment of CRC. Pathway enrichment analysis highlighted the involvement of Hippo signaling pathway in the regulation of miR-485-3p.

MOLECULAR BIOLOGY (2022)

Add to Collection

Article Oncology

LncRNAs driving feedback loops to boost drug resistance: sinuous pathways in cancer

David Sanchez-Marin et al.

Summary: This review summarizes the feedback loops regulated by lncRNAs to promote drug resistance and proposes strategies to identify and understand these feedback loops. This knowledge is crucial for optimizing the therapeutic use of oncological drugs.

CANCER LETTERS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis

Jiazhan Mei et al.

Summary: The study revealed that lncRNA SNHG6 has inhibitory effects on DDP resistance and progression of GC by sponging miR-1297 and regulating BCL-2 expression.

BIOSCIENCE REPORTS (2021)

Add to Collection

Editorial Material Oncology

LncRNA SNHG6 promotes breast cancer progression and epithelial-mesenchymal transition via miR-543/LAMC1 axis

You-Quan Wang et al.

Summary: The SNHG6/miR-543/LAMC1 axis plays a crucial role in breast cancer by regulating cell proliferation, migration, invasion, and apoptosis, promoting the development of the disease. This study provides a new direction for the development of therapeutic strategies for breast cancer.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Add to Collection

Article Medicine, Research & Experimental

Dual role of microRNA-1297 in the suppression and progression of human malignancies

Shahin Alizadeh-Fanalou et al.

Summary: miR-1297, a microRNA with dual functions, exhibits abnormal expression in various human cancers, acting as both a tumor suppressor and an oncogene.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Review Oncology

From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells

Jessica Fernanda Barazetti et al.

Summary: Breast cancer is a common disease that often recurs due to resistance to tamoxifen. Understanding estrogen receptor-positive breast cancer tumors, which are the most common subtype, is crucial for more effective treatment. Non-coding RNAs play a role in tamoxifen resistance and further exploration of their mechanisms may lead to more personalized and targeted therapies.

CANCERS (2021)

Add to Collection

Article Cell Biology

Long Non-Coding RNA SNHG6 Supports Glioma Progression Through Upregulation of Notch1, Sox2, and EMT

Jing Nie et al.

Summary: The study reveals SNHG6 and Notch1 as valid targets for glioma therapy, as their regulation can inhibit EMT and the expression of cancer stem cell marker Sox2, leading to apoptosis of glioma cells.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Article Oncology

Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020

Shaoyuan Lei et al.

Summary: Breast cancer is the most commonly diagnosed cancer and leading cause of cancer death among women worldwide, with significant variations in incidence and mortality rates among different countries. Global burden of breast cancer is rapidly increasing, with a need for increased health awareness, effective prevention strategies, and improved access to medical treatment.

CANCER COMMUNICATIONS (2021)

Add to Collection

Article Neurosciences

MiR-325-3p functions as a suppressor miRNA and inhibits the proliferation and metastasis of glioma through targeting FOXM1

Qijiang Xiong et al.

Summary: Glioma is a malignant brain tumor with low expression levels of miR-325-3p, whose upregulation can suppress tumor cell proliferation, migration, and invasion, possibly through targeting FOXM1. This suggests that miR-325-3p could be a potential new therapeutic target for treating glioma.

JOURNAL OF INTEGRATIVE NEUROSCIENCE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway

Deng-Pan Wu et al.

Summary: This study revealed that epithelial-mesenchymal transition plays a crucial role in Tamoxifen resistance in breast cancer, and increasing connexin 43 expression can reverse Tamoxifen resistance. The findings suggest that connexin 43 could be a prognostic marker and therapeutic target for breast cancer treatment.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

DIANA-LncBase v3: indexing experimentally supported miRNA targets on non-coding transcripts

Dimitra Karagkouni et al.

NUCLEIC ACIDS RESEARCH (2020)

Add to Collection

Review Oncology

The Dual Role of miR-186 in Cancers: Oncomir Battling With Tumor Suppressor miRNA

Ying Xiang et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Article Cell Biology

LncRNA SNHG6 plays an oncogenic role in colorectal cancer and can be used as a prognostic biomarker for solid tumors

Xiang Yao et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Add to Collection

Article Oncology

Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p

Ke Li et al.

THORACIC CANCER (2020)

Add to Collection

Review Oncology

Long noncoding RNA SNHG6 mainly functions as a competing endogenous RNA in human tumors

Hui-shan Wang et al.

CANCER CELL INTERNATIONAL (2020)

Add to Collection

Review Oncology

The prognostic value of lncRNA SNHG6 in cancer patients

Haixiang Shen et al.

CANCER CELL INTERNATIONAL (2020)

Add to Collection

Article Oncology

Long non-coding RNA SNHG6 regulates the sensitivity of prostate cancer cells to paclitaxel by sponging miR-186

Chunhui Cao et al.

CANCER CELL INTERNATIONAL (2020)

Add to Collection

Article Oncology

LncRNA SNHG6 enhances the radioresistance and promotes the growth of cervical cancer cells by sponging miR-485-3p

Jin Liu et al.

CANCER CELL INTERNATIONAL (2020)

Add to Collection

Article Oncology

Long non-coding RNA SNHG6 promotes tumorigenesis in melanoma cells via the microRNA-101-3p/RAP2B axis

Hong Zhou et al.

ONCOLOGY LETTERS (2020)

Add to Collection

Review Pharmacology & Pharmacy

Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer

Jingwei Yao et al.

FRONTIERS IN PHARMACOLOGY (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

SNHG6 Interacted with miR-325-3p to Regulate Cisplatin Resistance of Gastric Cancer by Targeting GITR

Tuanhe Sun et al.

ONCOTARGETS AND THERAPY (2020)

Add to Collection

Article Multidisciplinary Sciences

The tumor suppressor microRNA let-7 inhibits human LINE-1 retrotransposition

Pablo Tristan-Ramos et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Oncology

The Role of Long Noncoding RNAs in Antiestrogen Resistance in Breast Cancer: An Overview and Update

Lan Huang et al.

JOURNAL OF BREAST CANCER (2020)

Add to Collection

Article Oncology

Long noncoding RNA SNHG6 promotes proliferation and angiogenesis of cholangiocarcinoma cells through sponging miR-101-3p and activation of E2F8

Huishan Wang et al.

JOURNAL OF CANCER (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

LncRNA SNHG6 Inhibits Apoptosis by Regulating EZH2 Expression via the Sponging of MiR-101-3p in Esophageal Squamous-Cell Carcinoma

Jiang Wang et al.

ONCOTARGETS AND THERAPY (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis

Mingyuan Zhang et al.

ONCOTARGETS AND THERAPY (2019)

Add to Collection

Article Multidisciplinary Sciences

MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer

Flavia Biamonte et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Gastroenterology & Hepatology

SNHG 6 promotes the progression of Colon and Rectal adenocarcinoma via miR-101-3p and Wnt/β-catenin signaling pathway

Qianwen Shao et al.

BMC GASTROENTEROLOGY (2019)

Add to Collection

Article Oncology

LncRNA SNHG6 promotes chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in colorectal cancer cells

Xinke Wang et al.

CANCER CELL INTERNATIONAL (2019)

Add to Collection

Article Multidisciplinary Sciences

miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB

Yu Gao et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Medicine, General & Internal

LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1

Xinke Wang et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p

Qiang Meng et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2018)

Add to Collection

Article Cell Biology

Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer

Yang Li et al.

CELL DEATH & DISEASE (2017)

Add to Collection

Article Cell Biology

LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p

Kai Yan et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Add to Collection

Article Oncology

Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma

Lei Chang et al.

CANCER LETTERS (2016)

Add to Collection

Article Oncology

Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4

Aamir Ahmad et al.

BMC CANCER (2015)

Add to Collection

Article Biochemistry & Molecular Biology

MicroRNA-101-mediated Akt activation and estrogen-independent growth

M. Sachdeva et al.

ONCOGENE (2011)

Add to Collection

Review Pharmacology & Pharmacy

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance

Zhiwei Wang et al.

DRUG RESISTANCE UPDATES (2010)

Add to Collection

Review Biochemistry & Molecular Biology

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

A. Singh et al.

ONCOGENE (2010)

Add to Collection

Review Oncology

Modelling breast cancer: one size does not fit all

Tracy Vargo-Gogola et al.

NATURE REVIEWS CANCER (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.